Toward an Improved Understanding of the Precipitation Behavior of Weakly Basic Drugs from Oral Lipid-Based Formulations
Toward an Improved Understanding of the Precipitation Behavior of Weakly Basic Drugs from Oral Lipid-Based Formulations
复制标题
DOI：
10.1002/jps.23892
复制
发表时间：
2014-04-01
影响因子：
3.8
通讯作者：
Kuentz, Martin
中科院分区：
文献类型：
--
作者：
Stillhart, Cordula;Duerr, Desiree;Kuentz, Martin
本研究的目的是分析脂基制剂（LBF）分散和消化对弱碱性药物沉淀行为的影响。氯雷他定和卡维地洛在一系列LBF中配制，并在模拟分散和消化条件（禁食状态）下分析药物增溶。对过饱和度和药物沉淀的程度以及沉淀药物的固态性质和再溶解行为进行了评估。X-射线粉末衍射表明卡维地洛在分散时以结晶形式沉淀，但有趣的是，该药物在脂解过程中产生无定形沉淀。相反，氯雷他定在制剂分散和消化过程中均以结晶物质沉淀。未观察到制剂组成对沉淀类型的影响。这些结果表明，体外条件（分散与消化）在很大程度上影响沉淀弱碱的固态性质。在不同实验条件下沉淀药物的固态表征应常规进行处方筛选，以更好地了解LBF的生物制药行为。因此，这些发现对于使用弱碱性药物的LBF的药物开发和体外评估具有很高的实际意义。(c)2014 Wiley Periodicals，Inc.和美国药学协会药物科学杂志103：1194-1203，2014
The aim of the present study was to analyze the impact of lipid-based formulation (LBF) dispersion and digestion on the precipitation behavior of weakly basic drugs. Loratadine and carvedilol were formulated in a range of LBFs and drug solubilization was analyzed under simulated dispersive and digestive conditions (fasted state). The extent of supersaturation and drug precipitation as well as the solid-state properties and redissolution behavior of precipitated drugs were assessed. X-ray powder diffraction indicated that carvedilol precipitated in a crystalline form upon dispersion, but interestingly, this drug gave an amorphous precipitate during lipolysis. In contrast, loratadine precipitated as crystalline material during both formulation dispersion and digestion. No influence of the formulation composition on the type of precipitation was observed. These results suggested that invitro conditions (dispersive versus digestive) largely influenced the solid-state properties of precipitating weak bases. Solid-state characterization of precipitated drugs under different experimental conditions should be routinely performed in formulation screening to better understand the biopharmaceutical behavior of LBFs. Hence, these findings are of high practical importance for the pharmaceutical development and invitro assessment of LBFs using weakly basic drugs. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:1194-1203, 2014